| Dr June Y Leland, MD | |
|
5537 Sea Forest Dr, Apartment 201, New Port Richey, FL 34652-3205 | |
| (813) 395-3455 | |
| (813) 903-3637 |
| Full Name | Dr June Y Leland |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 5537 Sea Forest Dr, New Port Richey, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285690503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | ME0066200 (Florida) | Primary |
| 207RH0002X | Internal Medicine - Hospice And Palliative Medicine | ME0066200 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr June Y Leland, MD 5537 Sea Forest Dr, Apartment 201, New Port Richey, FL 34652-3205 Ph: (813) 395-3455 | Dr June Y Leland, MD 5537 Sea Forest Dr, Apartment 201, New Port Richey, FL 34652-3205 Ph: (813) 395-3455 |
News Archive
The current incidence and prevalence of tuberculosis are severely straining the capacity of some National Tuberculosis Control Programmes to successfully administer the WHO recommended standard six-month regimen.
Deforestation in Brazil has been linked to an increase in malaria incidence there, according to findings published online Wednesday in the CDC journal, Emerging Infectious Diseases, Agence France-Presse reports.
Atrial fibrillation is the most prevalent form of cardiac arrhythmia, affecting up to 6 million people in the U.S. alone. Common treatments for severe forms of the erratic beating phenomenon are controversial, and guided by detection methods that are not yet standardized or fully refined.
Tikcro Technologies Ltd. today announced that BioCancell Therapeutics, Inc., concluded the first 18 patient group treated pursuant to a Phase IIb clinical trial of the drug candidate BC-819 for use in superficial bladder cancer. These patients had not responded to conventional treatment.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced plans to submit a Phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of 2010. The Company has added the talent of Peter G. Traber, M.D., to its FDA approval strategy and trial design team.
› Verified 5 days ago
Dr. Bassem Salti Zeidan Jr., MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 9332 State Road 54 Ste 202, New Port Richey, FL 34655 Phone: 516-840-5007 | |
Dr. Maria E. Colon, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 9912 Little Rd, New Port Richey, FL 34654 Phone: 727-869-4100 | |
Dr. Sahasra Naman, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 5509 Grand Blvd, Suite 300, New Port Richey, FL 34652 Phone: 727-232-0644 Fax: 866-615-6461 | |
Dr. Lily N Jones, D.O. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8607 Easthaven Ct Ste 101, New Port Richey, FL 34655 Phone: 727-669-6800 Fax: 727-669-2540 | |
Dr. Udayabhasker Gangapuram Reddy, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4807 Us Highway 19, Suite 201, New Port Richey, FL 34652 Phone: 727-847-9505 Fax: 727-847-9509 | |
Dr. Kiran Tirumalasetty, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9332 State Road 54 Ste 202, New Port Richey, FL 34655 Phone: 727-597-4441 Fax: 727-597-4445 | |
Dr. Panagiota Aggeletos, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 9912 Little Rd, (va Outpatient Clinic- Pasco), New Port Richey, FL 34654 Phone: 727-869-4100 Fax: 727-869-4197 |